Pulmonary circulation and it's clinical aspects full details for md exams 10marks answer from fishman and murray only

Reading File
Finding Sources
Finding Sources

Give crisp concise complete answer

Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
This answer covers all high-yield MD exam points directly from Fishman and Murray. Quick orientation of what's inside:
SectionKey Exam Points
AnatomyHilum entry, peribronchovascular sheath, capillary surface 50-70 m²
Normal pressuresmPAP 14 (8-20), PVR 0.9 WU, PAWP 8 mmHg
PVR formula(mPAP - LAP)/CO; Swan-Ganz measurement; thermodilution
Recruitment & distensionMechanism for PVR fall with exercise
West zonesZone 1/2/3 + Zone 4; gravity model
HPVMechanism (redox/ROS), NO & endothelin role, fetal circulation, clinical traps
PH definitionmPAP >20 mmHg (updated), pre vs postcapillary criteria, DPG vs TPG
RV-PA couplingEes/Ea 1.5-2, TAPSE/sPAP ratio
Clinical: PECTPA gold standard, D-dimer, Wells/PERC, >50% obstruction for PH
Clinical: PAHRHC required, vasoreactivity testing, endothelin antagonists
Clinical: EdemaStarling forces, HAPE, peribronchovascular cuffing

No for 10 marks re

Here is the restructured, crisp 10-mark exam answer - every point from Fishman and Murray, nothing extra:

PULMONARY CIRCULATION AND CLINICAL ASPECTS


1. INTRODUCTION

The pulmonary circulation is a high-flow, low-pressure system evolved to optimise gas exchange. The alveolo-capillary membrane is only 0.3 μm thick. The RV is a thin-walled flow generator (not a pressure generator). (Fishman's, Ch.13)

2. ANATOMY

(Murray & Nadel, Ch.1)
  • Pulmonary artery enters each lung at the hilum alongside the bronchus in a loose peribronchovascular connective tissue sheath
  • Artery branches with each airway generation down to the respiratory bronchiole - ensuring V/Q matching at every level
  • Pulmonary veins lie as far from airways as possible (Miller's dictum) - peripherally in connective tissue septa
  • Total capillary surface area = 50-70 m² (key to efficient gas exchange)
  • Capillary volume = 60-200 mL; serves as a reservoir that can be recruited

3. NORMAL PRESSURES

(Fishman's, Table 13-1)
ParameterMeanNormal Range
mPAP14 mmHg8-20
PAP systolic/diastolic21/9 mmHg13-29 / 3-15
PAWP8 mmHg2-14
PVR0.9 Wood units0.2-1.8
Cardiac Output7.3 L/min5.0-9.5
Compare: systemic mPAP ~100 mmHg for the same cardiac output - pulmonary PVR is ~1/10th systemic.

4. PULMONARY VASCULAR RESISTANCE (PVR)

PVR = (mPAP − PAWP) / CO
  • Measured via Swan-Ganz catheter (triple-lumen balloon-tipped, introduced by Swan, Ganz & Forrester, 1970s)
  • PAWP estimates LAP (left atrial pressure)
  • CO by thermodilution (5-10 mL cold saline into RA) or direct Fick (CO = VO₂ / CaO₂ - CvO₂)
PVR is NOT fixed - it falls when pressure rises, by two mechanisms:
  1. Recruitment - previously closed capillaries open
  2. Distension - increase in caliber of open vessels
This fall in PVR during exercise limits RV work.
Effect of hematocrit: PVR rises exponentially with hematocrit - clinically important in polycythemia (COPD, altitude). (Murray & Nadel, Ch.10; Fishman's, Ch.13)

5. DISTRIBUTION OF BLOOD FLOW - WEST ZONES

(Murray & Nadel, Ch.10)
The upright lung is ~30 cm tall; hydrostatic pressure difference = 23 mmHg - large relative to driving pressure.
ZonePressure RelationshipFlow
Zone 1 (apex)PA > Pa > PvNo flow (alveolar dead space) - not present normally
Zone 2 (middle)Pa > PA > PvIntermittent; flow ∝ Pa − PA
Zone 3 (base)Pa > Pv > PAContinuous; flow ∝ Pa − Pv
Zone 4 (extreme base)Interstitial P > PaReduced flow (extra-alveolar vessel compression)
(Pa = pulmonary arterial; PA = alveolar; Pv = pulmonary venous pressure)
Non-gravitational factors: Fractal branching, regional resistance differences; at weightlessness (astronauts), distribution becomes near-uniform.
Abnormal patterns:
  • Pulmonary embolism → perfusion defect with normal ventilation (V/Q mismatch)
  • Left heart failure → cephalization (upper zone diversion) from raised PAWP
  • COPD, fibrosis → patchy reduction in regional flow

6. HYPOXIC PULMONARY VASOCONSTRICTION (HPV)

(Murray & Nadel, Ch.10; Fishman's, Ch.13)
Definition: Local alveolar hypoxia (PO₂ < 60 mmHg) → pulmonary vasoconstriction → diverts blood to better-ventilated areas.
Unique - systemic vessels DILATE in hypoxia; pulmonary vessels CONSTRICT.
Sensor: Alveolar PO₂ (not blood PO₂). Proven by perfusing lung with high-PO₂ blood under hypoxic alveolar conditions - vasoconstriction still occurs.
Site: Predominantly small pulmonary arteries and arterioles (precapillary).
Does NOT require autonomic innervation (persists in transplanted lungs).
Mechanisms - Two Hypotheses:
HypothesisMechanism
Redox hypothesisHypoxia → ↓ mitochondrial ROS → K⁺ channel (Kv1.5) closure → membrane depolarisation → voltage-gated Ca²⁺ entry → vasoconstriction
ROS hypothesisHypoxia → complex III generates ROS → Ca²⁺ influx + SR Ca²⁺ release → Rho kinase (ROCK) activation → myofilament sensitisation → vasoconstriction
Modulators:
  • NO (endothelium-derived): vasodilator; inhibits HPV; inhaled NO (~20 ppm) reverses HPV
  • Endothelins (endothelium-derived): vasoconstrictor; augment HPV → endothelin receptor antagonists are key PAH drugs
  • Metabolic acidosis: enhances HPV; metabolic alkalosis: attenuates HPV
Physiologic roles:
  • Improves V/Q matching in localised lung disease
  • Fetal circulation: HPV keeps PVR high → only 15% CO to fetal lungs
  • Bronchodilators (β-agonists) inhibit HPV → V/Q worsens → ↓ PaO₂ (clinical trap in asthma)

7. DEFINITION OF PULMONARY HYPERTENSION

(Fishman's, Ch.13 - current expert consensus)
CategoryCriteria
Pulmonary HypertensionmPAP > 20 mmHg (updated threshold; old: >25 mmHg)
Precapillary PHmPAP >20 + PAWP ≤15 mmHg + PVR ≥3 Wood units
Postcapillary PHmPAP >20 + PAWP >15 mmHg
Diastolic Pressure Gradient (DPG) = dPAP − PAWP
  • Upper limit of normal: ~5-7 mmHg
  • DPG >7 mmHg in heart failure = poor survival (precapillary component added)
  • DPG is superior to TPG (mPAP−PAWP) for diagnosing pulmonary vascular disease in left heart failure
Embolic obstruction threshold (Fishman's Fig 13-8):
  • 50% obstruction needed to raise mPAP >25 mmHg
  • Severe PH (mPAP ~50 mmHg) = ~80% obstruction

8. RV-PULMONARY ARTERIAL COUPLING

(Fishman's, Ch.13)
  • Optimal coupling: Ees/Ea = 1.5-2 (RV end-systolic elastance / arterial elastance)
  • EF = 1 - mPAP/Pmax
  • When EF falls <35% or SV/ESV <52% → RV dilates → systemic congestion
  • Noninvasive surrogate: TAPSE/sPAP ratio (echocardiography) - validated in PAH, HF, chronic lung disease

9. CLINICAL ASPECTS

A. Pulmonary Arterial Hypertension (PAH)

(Murray & Nadel, Ch.9)
  • Workup: ECG, ABG, CXR, PFTs, 6-min walk test, BNP, echo
  • Right heart catheterisation - mandatory to confirm diagnosis and severity
  • Acute vasoreactivity test: inhaled NO / epoprostenol / adenosine → guides calcium channel blocker use
  • Chronic thromboembolic PH: V/Q scan + CT pulmonary angiography

B. Pulmonary Embolism

(Fishman's, Ch.28; Murray & Nadel, Ch.9)
  • Arises from lower extremity DVT; elevated troponin = high short-term mortality
  • CTPA - current gold standard; high NPV; limited for subsegmental clots
  • D-dimer - high NPV; poor specificity in pregnancy/surgery; negative D-dimer + low pretest probability avoids CT in ~50% outpatients
  • V/Q scan (SPECT) - preferred in young women and pregnancy (lower breast dose); limited by poor specificity (PIOPED study)
  • Wells, Geneva, PERC scores - pretest probability assessment (frequently underused)
  • Leg Doppler US - first test if clinical DVT signs present

C. Pulmonary Edema

(Murray & Nadel, Ch.1; Fishman's, Ch.91)
  • Fluid first accumulates in peribronchovascular connective tissue sheaths (seen as cuffing on CXR/CT)
  • HAPE (High-Altitude Pulmonary Edema): global HPV → uneven vasoconstriction → high shear stress + vascular injury → edema
    • Treatment: immediate descent, supplemental O₂, nifedipine

D. Effects of Lung/Heart Disease

  • COPD → patchy HPV → if global hypoxia sustained → PH → cor pulmonale (RV hypertrophy/failure)
  • Left-to-right shunts → increased flow → vascular remodelling → Eisenmenger syndrome (irreversible precapillary PH)
  • Altitude: acute HPV → reversible; weeks-months exposure → structural arteriolar remodelling → RV hypertrophy

10. SUMMARY

(Fishman's Ch.13 - verbatim key point)
"The pulmonary circulation is a high-flow, low-pressure circuit with average PVR of 1 Wood unit in young adults rising to 2.5 Wood units over 4-6 decades. PVR falls with exercise. Distribution of perfusion is gravity-dependent, corrected by HPV. Optimal RV-PA coupling ratio is 1.5-2."

References: Fishman's Pulmonary Diseases & Disorders (Ch. 13, 28, 91) | Murray & Nadel's Textbook of Respiratory Medicine (Ch. 1, 9, 10)
This is a shared conversation. Sign in to Orris to start your own chat.